Stock NUMD NU-MED PLUS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nu-Med Plus, Inc.

Equities

NUMD

US67021R1041

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 09:42:33 2024-05-15 am EDT 		5-day change 1st Jan Change
0.0481 USD -3.57% Intraday chart for Nu-Med Plus, Inc. -25.97% +18.81%
Apr. 28 Nu-Med Plus, Inc. completed the acquisition of Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner. CI
Mar. 26 Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 30.7 18.68 45.21 2.777 1.342 3.38
Enterprise Value (EV) 1 30.77 18.91 45.03 2.774 1.369 3.473
P/E ratio -25 x -19.8 x -22.5 x -3.09 x -10.1 x -26.3 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -26.7 x -18.8 x -22.7 x -3.34 x -7.61 x -29.4 x
EV / FCF -132 x 487 x -370 x 23.1 x -7.65 x -180 x
FCF Yield -0.76% 0.21% -0.27% 4.33% -13.1% -0.56%
Price to Book 638 x -54 x 98.2 x -21 x -21.3 x -23 x
Nbr of stocks (in thousands) 40,934 41,514 50,228 79,348 81,348 83,548
Reference price 2 0.7500 0.4500 0.9000 0.0350 0.0165 0.0404
Announcement Date 4/1/19 3/30/20 3/31/21 3/31/22 3/29/23 3/26/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA 1 -1.155 -1.006 -1.983 -0.8301 -0.1799 -0.1183
EBIT 1 -1.169 -1.019 -1.995 -0.8394 -0.1822 -0.1205
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -1.189 -1.037 -2.009 -0.8301 -0.1302 -0.1255
Net income 1 -1.189 -1.037 -2.009 -0.8301 -0.1302 -0.1255
Net margin - - - - - -
EPS 2 -0.0300 -0.0228 -0.0400 -0.0113 -0.001628 -0.001536
Free Cash Flow 1 -0.2329 0.0388 -0.1217 0.12 -0.1791 -0.0193
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/1/19 3/30/20 3/31/21 3/31/22 3/29/23 3/26/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.07 0.23 - - 0.03 0.09
Net Cash position 1 - - 0.17 0 - -
Leverage (Debt/EBITDA) -0.0637 x -0.23 x - - -0.149 x -0.788 x
Free Cash Flow 1 -0.23 0.04 -0.12 0.12 -0.18 -0.02
ROE (net income / shareholders' equity) -2,036% 644% -4,131% -495% 133% 120%
ROA (Net income/ Total Assets) -176% -272% -414% -181% -224% -162%
Assets 1 0.6749 0.3814 0.4858 0.4583 0.0581 0.0775
Book Value Per Share 2 0 -0.0100 0.0100 -0 -0 -0
Cash Flow per Share 2 0 0 0 0 0 0
Capex 1 0.01 - - - - -
Capex / Sales - - - - - -
Announcement Date 4/1/19 3/30/20 3/31/21 3/31/22 3/29/23 3/26/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
NU-MED PLUS, INC. Stock Nu-Med Plus, Inc.
+18.81% 4.02M
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.98% 182B
MEDTRONIC PLC Stock Medtronic plc
+2.84% 112B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.68% 68.58B
DEXCOM, INC. Stock DexCom, Inc.
+4.53% 51.58B
CENCORA, INC. Stock Cencora, Inc.
+8.00% 44.24B
HOYA CORPORATION Stock Hoya Corporation
+9.65% 43.65B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+25.30% 32.46B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-0.17% 25.61B
TERUMO CORPORATION Stock Terumo Corporation
+21.57% 25.99B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. NUMD Stock
  4. Financials Nu-Med Plus, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW